Pandemic has brought new sense of awareness to respiratory diseases and clinops.
Susan Wood, PhD
Advertisement
President & CEO of VIDA Diagnostics
Articles by Susan Wood, PhD
Steps that investigators and sponsors can take to streamline trials and accelerate the time to market for lifesaving therapies.
Advertisement
Latest Updated Articles
How COVID is Forcing a Reckoning in Respiratory Clinical TrialsPublished: July 12th 2022 | Updated:
- Streamlining the Complex Respiratory Clinical Trial Infrastructure
Published: November 29th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
2
Moving Beyond Historical Site Data to Real-Time Patient Insight
3
ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials
4
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
5